Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not
暂无分享,去创建一个
[1] J. Belleroche,et al. Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB , 2013, European Journal of Human Genetics.
[2] Hideshi Kawakami,et al. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.
[3] M. P. David,et al. Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2 , 2013, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
[4] J. Hardy,et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. , 2013, JAMA neurology.
[5] L. Petrucelli,et al. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study , 2013, The Lancet Neurology.
[6] L. Timchenko. Molecular mechanisms of muscle atrophy in myotonic dystrophies. , 2013, The international journal of biochemistry & cell biology.
[7] R. Takahashi,et al. Optineurin suppression causes neuronal cell death via NF‐κB pathway , 2013, Journal of neurochemistry.
[8] L. Petrucelli,et al. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia , 2013, Acta Neuropathologica.
[9] E. Rogaeva,et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. , 2013, American journal of human genetics.
[10] Michel Goedert,et al. Tau pathology and neurodegeneration , 2013, The Lancet Neurology.
[11] M. Nalls,et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. , 2013, JAMA neurology.
[12] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[13] Kevin F. Bieniek,et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.
[14] V. Meininger,et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology , 2013, Acta Neuropathologica.
[15] Timothy P. Levine,et al. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs , 2013, Bioinform..
[16] P. S. St George-Hyslop,et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2012, Neurology.
[17] C. van Broeckhoven,et al. The genetics and neuropathology of frontotemporal lobar degeneration , 2012, Acta Neuropathologica.
[18] M. Corbo,et al. Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject , 2012, Neurobiology of Aging.
[19] Katherine R. Smith,et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. , 2012, American journal of human genetics.
[20] Marc Cruts,et al. Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.
[21] J. Grafman,et al. FUS and TDP43 genetic variability in FTD and CBS , 2012, Neurobiology of Aging.
[22] R. Rademakers. C9orf72 repeat expansions in patients with ALS and FTD , 2012, The Lancet Neurology.
[23] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[24] John L. Robinson,et al. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion , 2012, Acta Neuropathologica.
[25] J. Collinge,et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. , 2012, Brain : a journal of neurology.
[26] D. Neary,et al. Analysis of optineurin in frontotemporal lobar degeneration , 2012, Neurobiology of Aging.
[27] M. Bug,et al. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system , 2012, Nature Cell Biology.
[28] J. Rohrer,et al. Phenotypic signatures of genetic frontotemporal dementia. , 2011, Current opinion in neurology.
[29] T. Hortobágyi,et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.
[30] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[31] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[32] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[33] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[34] Sebastian A. Wagner,et al. Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth , 2011, Science.
[35] R. Takahashi,et al. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation , 2011, Acta Neuropathologica.
[36] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[37] Sonja W. Scholz,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2010, Neuron.
[38] H. Feldman,et al. Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin , 2010, Neuron.
[39] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[40] Paul G. Ince,et al. Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) , 2010, PloS one.
[41] William D Fraser,et al. Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.
[42] C. van Broeckhoven,et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations , 2010, Human molecular genetics.
[43] K. Sleegers,et al. Genetic contribution of FUS to frontotemporal lobar degeneration , 2010, Neurology.
[44] B. Dubois,et al. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. , 2010, Journal of Alzheimer's disease : JAD.
[45] N. Cairns,et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.
[46] J. Gal,et al. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin‐independent mechanism , 2009, Journal of neurochemistry.
[47] A. Pestronk,et al. Valosin-containing protein disease: Inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementia , 2009, Neuromuscular Disorders.
[48] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[49] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[50] Sara E. Miller,et al. Impaired Protein Aggregate Handling and Clearance Underlie the Pathogenesis of p97/VCP-associated Disease* , 2008, Journal of Biological Chemistry.
[51] Mitchell R Lunn,et al. Spinal muscular atrophy , 2008, The Lancet.
[52] L. Goldstein,et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice , 2008, Proceedings of the National Academy of Sciences.
[53] P. Hartikainen,et al. Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions Visualized With Ubiquitin-Binding Protein p62 Immunohistochemistry , 2008, Journal of neuropathology and experimental neurology.
[54] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[55] L. Peltonen,et al. Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease , 2008, Nature Genetics.
[56] Patrick Santens,et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. , 2008, Human molecular genetics.
[57] Masaaki Komatsu,et al. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.
[58] P. Johannsen,et al. A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3 , 2007, Journal of neuropathology and experimental neurology.
[59] N. Cairns,et al. TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.
[60] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[61] J. Collinge,et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) , 2006, Neurology.
[62] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[63] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[64] W. Dauer,et al. Loss of the Dystonia-Associated Protein TorsinA Selectively Disrupts the Neuronal Nuclear Envelope , 2005, Neuron.
[65] Holger Hummerich,et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.
[66] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[67] C. H. Ong,et al. Progranulin is a mediator of the wound response , 2003, Nature Medicine.
[68] Jacques P. Brown,et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.
[69] X. Breakefield,et al. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. , 2000, Human molecular genetics.
[70] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[71] H. Kornhuber,et al. Motor neuron disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[72] P. Favel,et al. [Affective disorders and dementia of the frontal lobe type. Hypothesis of a pathogenic relationship]. , 1994, L'Encephale.
[73] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.